Bristol-Myers Squibb Co (NYSE: BMY) is -1.45% lower on its value in year-to-date trading and has touched a low of $39.35 and a high of $61.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BMY stock was last observed hovering at around $55.36 in the last trading session, with the day’s gains setting it 0.38%.
Currently trading at $55.74, the stock is -1.72% and -2.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.35 million and changing 0.69% at the moment leaves the stock 12.58% off its SMA200. BMY registered 10.99% gain for a year compared to 6-month gain of 38.83%. The firm has a 50-day simple moving average (SMA 50) of $57.1968 and a 200-day simple moving average (SMA200) of $49.4992.
The stock witnessed a -1.61% loss in the last 1 month and extending the period to 3 months gives it a 6.78%, and is -1.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.63% over the week and 1.90% over the month.
Bristol-Myers Squibb Co (BMY) has around 34100 employees, a market worth around $113.05B and $47.44B in sales. Fwd P/E is 7.96. Profit margin for the company is -15.30%. Distance from 52-week low is 41.65% and -8.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.78%).
with sales reaching $11.53B over the same period.The EPS is expected to shrink by -87.96% this year, but quarterly earnings will post 5.45% year-over-year. Quarterly sales are estimated to grow 0.46% in year-over-year returns.
Bristol-Myers Squibb Co (BMY) Top Institutional Holders
2906.0 institutions hold shares in Bristol-Myers Squibb Co (BMY), with institutional investors hold 78.63% of the company’s shares. The shares outstanding are 2.03B, and float is at 2.03B with Short Float at 1.23%. Institutions hold 78.54% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 186.57 million shares valued at $7.75 billion. The investor’s holdings represent 9.2225% of the BMY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 158.66 million shares valued at $6.59 billion to account for 7.8428 of the shares outstanding. The other top investors are STATE STREET CORP which holds 91.45 million shares representing 4.5203% and valued at over $3.8 billion, while JPMORGAN CHASE & CO holds 3.6818 of the shares totaling 74.63 million with a market value of $3.1 billion.
Bristol-Myers Squibb Co (BMY) Insider Activity
The most recent transaction is an insider sale by Holzer Phil M, the company’s SVP and Controller. SEC filings show that Holzer Phil M sold 700 shares of the company’s common stock on Nov 04 ’24 at a price of $55.62 per share for a total of $38930.0. Following the sale, the insider now owns 11760.0 shares.
Bristol-Myers Squibb Co disclosed in a document filed with the SEC on Nov 01 ’24 that Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) bought a total of 1,830 shares of the company’s common stock. The trade occurred on Nov 01 ’24 and was made at $54.67 per share for $0.1 million. Following the transaction, the insider now directly holds 62109.0 shares of the BMY stock.
Still, SEC filings show that on Nov 04 ’24, Holzer Phil M (Officer) Proposed Sale 700 shares at an average price of $55.62 for $38930.0. The insider now directly holds shares of Bristol-Myers Squibb Co (BMY).
